These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 34189910)

  • 1. Mechanism of Vitamin D Receptor Ligand-Binding Domain Regulation Studied by gREST Simulations.
    Ekimoto T; Kudo T; Yamane T; Ikeguchi M
    J Chem Inf Model; 2021 Jul; 61(7):3625-3637. PubMed ID: 34189910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of Nuclear Receptor Ligands and Elucidation of Their Mechanisms of Action.
    Yamamoto K
    Chem Pharm Bull (Tokyo); 2019; 67(7):609-619. PubMed ID: 31257315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fine tuning of agonistic/antagonistic activity for vitamin D receptor by 22-alkyl chain length of ligands: 22S-Hexyl compound unexpectedly restored agonistic activity.
    Anami Y; Sakamaki Y; Itoh T; Inaba Y; Nakabayashi M; Ikura T; Ito N; Yamamoto K
    Bioorg Med Chem; 2015 Nov; 23(22):7274-81. PubMed ID: 26515040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apo- and Antagonist-Binding Structures of Vitamin D Receptor Ligand-Binding Domain Revealed by Hybrid Approach Combining Small-Angle X-ray Scattering and Molecular Dynamics.
    Anami Y; Shimizu N; Ekimoto T; Egawa D; Itoh T; Ikeguchi M; Yamamoto K
    J Med Chem; 2016 Sep; 59(17):7888-900. PubMed ID: 27535484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ligand-specific structural changes in the vitamin D receptor in solution.
    Singarapu KK; Zhu J; Tonelli M; Rao H; Assadi-Porter FM; Westler WM; DeLuca HF; Markley JL
    Biochemistry; 2011 Dec; 50(51):11025-33. PubMed ID: 22112050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A mixed population of antagonist and agonist binding conformers in a single crystal explains partial agonism against vitamin D receptor: active vitamin D analogues with 22R-alkyl group.
    Anami Y; Itoh T; Egawa D; Yoshimoto N; Yamamoto K
    J Med Chem; 2014 May; 57(10):4351-67. PubMed ID: 24742174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular modeling, affinity labeling, and site-directed mutagenesis define the key points of interaction between the ligand-binding domain of the vitamin D nuclear receptor and 1 alpha,25-dihydroxyvitamin D3.
    Swamy N; Xu W; Paz N; Hsieh JC; Haussler MR; Maalouf GJ; Mohr SC; Ray R
    Biochemistry; 2000 Oct; 39(40):12162-71. PubMed ID: 11015194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between Structure and Conformational Change of the Vitamin D Receptor Ligand Binding Domain in 1α,25-Dihydroxyvitamin D3 Signaling.
    Wan LY; Zhang YQ; Chen MD; Du YQ; Liu CB; Wu JF
    Molecules; 2015 Nov; 20(11):20473-86. PubMed ID: 26593892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The conformational dynamics of H2-H3n and S2-H6 in gating ligand entry into the buried binding cavity of vitamin D receptor.
    Tee WV; Ripen AM; Mohamad SB
    Sci Rep; 2016 Oct; 6():35937. PubMed ID: 27786277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Butyl pocket formation in the vitamin D receptor strongly affects the agonistic or antagonistic behavior of ligands.
    Yoshimoto N; Sakamaki Y; Haeta M; Kato A; Inaba Y; Itoh T; Nakabayashi M; Ito N; Yamamoto K
    J Med Chem; 2012 May; 55(9):4373-81. PubMed ID: 22512505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of vitamin D analogs modulating the pocket structure of vitamin D receptor.
    Yamamoto K; Anami Y; Itoh T
    Curr Top Med Chem; 2014; 14(21):2378-87. PubMed ID: 25537068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural Insights into the Ligand Binding Domain of the Glucocorticoid Receptor: A Molecular Dynamics Study.
    Alves NRC; Pecci A; Alvarez LD
    J Chem Inf Model; 2020 Feb; 60(2):794-804. PubMed ID: 31689103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Critical role of helix 12 of the vitamin D(3) receptor for the partial agonism of carboxylic ester antagonists.
    Väisänen S; Peräkylä M; Kärkkäinen JI; Steinmeyer A; Carlberg C
    J Mol Biol; 2002 Jan; 315(2):229-38. PubMed ID: 11779241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crystal structure of the vitamin D nuclear receptor ligand binding domain in complex with a locked side chain analog of calcitriol.
    Rochel N; Hourai S; Pérez-García X; Rumbo A; Mourino A; Moras D
    Arch Biochem Biophys; 2007 Apr; 460(2):172-6. PubMed ID: 17346665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structurally and functionally important amino acids of the agonistic conformation of the human vitamin D receptor.
    Väisänen S; Ryhänen S; Saarela JT; Peräkylä M; Andersin T; Mäenpää PH
    Mol Pharmacol; 2002 Oct; 62(4):788-94. PubMed ID: 12237325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in Vitamin D Receptor Function and Evolution Based on the 3D Structure of the Lamprey Ligand-Binding Domain.
    Sigüeiro R; Bianchetti L; Peluso-Iltis C; Chalhoub S; Dejaegere A; Osz J; Rochel N
    J Med Chem; 2022 Apr; 65(7):5821-5829. PubMed ID: 35302785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conformational Diversity of the Helix 12 of the Ligand Binding Domain of PPARγ and Functional Implications.
    Batista MR; Martínez L
    J Phys Chem B; 2015 Dec; 119(50):15418-29. PubMed ID: 26598113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural Studies of Vitamin D Nuclear Receptor Ligand-Binding Properties.
    Belorusova AY; Rochel N
    Vitam Horm; 2016; 100():83-116. PubMed ID: 26827949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Agonist and antagonist binding to the nuclear vitamin D receptor: dynamics, mutation effects and functional implications.
    Yaghmaei S; Roberts C; Ai R; Mizwicki MT; Chang CE
    In Silico Pharmacol; 2013; 1():2. PubMed ID: 25505647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Why do we need a three-dimensional architecture of the ligand-binding domain of the nuclear 1alpha,25-dihydroxyvitamin D(3) receptor?
    Mohr SC; Swamy N; Xu W; Ray R
    Steroids; 2001; 66(3-5):189-201. PubMed ID: 11179726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.